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Abstract
Background: A chronic compressed dorsal root ganglion (CCD) in rat produces pain behavior and an enhanced
excitability of neurons within the compressed ganglion. Kir2.1 is an inwardly rectifying potassium channel that acts
to stabilize the resting potential of certain cell types. We hypothesized that an inducible expression of Kir2.1
channels in CCD neurons might suppress neuronal excitability in the dorsal root ganglion (DRG) and reduce the
associated pain behavior.
Results: We delivered, by microinjection into the fourth lumbar (L4) DRG, an adenoviral vector containing a reporter
gene encoding the enhanced green fluorescent protein (GFP) and a Kir2.1 channel (AdKir). At the same time the
ganglion was compressed by implantation of a rod through the intervertebral foramen (CCD). The in vivo expression
of the transferred gene was controlled by an ecdysone analog via an ecdysone-inducible promoter in the viral
vector. In comparison with the effects of vehicle or a control vector containing only the GFP gene, AdKir significantly
reduced the neuronal hyperexcitability after CCD. Electrophysiological recordings, in vivo, from nociceptive and
non-nociceptive DRG neurons expressing the virally produced Kir2.1 channels revealed a hyperpolarized resting
membrane potential, an increased rheobase, and lack of spontaneous activity. Inducing the Kir2.1 gene at the
beginning of CCD surgery partially prevented the development of mechanical hyperalgesia. However, a delayed
induction of the Kir2.1 gene (3 days after CCD surgery) produced no significant effect on the pain behavior.
Conclusions: We found that an inducible expression of Kir2.1 channels in chronically compressed DRG neurons
can effectively suppress the neuronal excitability and, if induced at the beginning of CCD injury, prevent the
development of hyperalgesia. We hypothesize that a higher level of neuronal hyperexcitability in the DRG is
required to initiate than to maintain the hyperalgesia and that the hyperexcitability contributing to neuropathic
pain is best inhibited as soon as possible after injury.
Background
The increased excitability of dorsal root ganglion (DRG)
neurons associated with an injury of a peripheral nerve
or the ganglion may contribute to pain-related behaviors
in different animal models of neuropathic pain. After a
chronic compression of the DRG (CCD) which produced
pain and hyperalgesia in rats, the somata of DRG neurons
became hyperexcitable, some with spontaneous activity
(SA), both in the intact ganglion and after acute dissocia-
tion and placement in culture [1-5].
An adenoviral vector carrying the inwardly rectifying
potassium channel, Kir2.1 was shown to reduce the excit-
ability of superior cervical ganglion neurons, in vitro [6].
In the present study, transgenic delivery in vivo was
achieved by a sub-epineurial injection of recombinant
adenoviral vectors into the DRG of adult rats (Figure 1).
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an ecdysone analog in vivo via an ecdysone-inducible
promoter in the viral vector [7]. By applying adenoviral
vectors carrying Kir2.1, we expected to decrease the
excitability of DRG neurons, and reduce the pain-related
behaviors of the animal after CCD surgery. Some preli-
minary results of this study have been published in
abstract form [8,9].
Results
Adenoviral vectors induced mild mechanical hyperalgesia
in naïve rats
We first examined the behavioral effects of injections of
the viral vectors in naïve rats. The injection of vehicle to
the L4 DRG caused a slight and transient decrease of the
mechanical withdrawal threshold (mechanical hyperalge-
sia) in the ipsilateral hindpaw that recovered after three
days (Figure 2A, dashed line). Either the control vector,
AdEGI, containing only the enhanced green fluorescent
protein gene or the vector containing the Kir2.1 gene
(AdKir) produced, on the ipsilateral (but not contralateral
foot), a mild mechanical hyperalgesia that lasted for the
duration of behavioral testing (14 days, Figure 2A). Thus,
t h ep r e s e n c eo fa na d e n o v i r a lv e c t o ri nt h eD R Ge v e n
without induction of the transferred gene, produced a
mild hyperalgesia on the ipsilateral foot.
In previous studies, a single injection of the inducing
agent was sufficient in the rat to induce, within 24 hours,
t h ee x p r e s s i o no ft h et a r g e tg e n et r a n s f e r r e db ya d e n o -
viral vectors. The expression lasted for at least 10 days
but could be maintained by repetitive injection of the
inducing agent [7]. In the present study, we defined an
induction as “immediate” or “delayed” according to
whether the inducing agent was delivered, respectively, at
the same time or three days after, the injection of the
viral vector. The intraperitoneal injection of the inducing
agent did not affect the hindpaw withdrawal threshold to
mechanical stimulation in naïve, vehicle- or AdEGI-
injected rats. In comparison to AdEGI, AdKir produced a
similar level of mechanical hyperalgesia, regardless of
whether its induction was immediate (Figure 2A) or
delayed (Figure 2B).
The mechanical hyperalgesia produced by CCD was
partially alleviated by immediate, but not delayed,
induction of the Kir gene
CCD surgery, accompanied by the injection of either the
control viral vector in vehicle or the vehicle alone, pro-
duced a long-lasting mechanical hyperalgesia on the ipsi-
lateral foot (Figure 3A) that was indistinguishable from
that obtained in response to CCD alone [4], but signifi-
cantly greater than that obtained in response to either
viral vector alone (Figure 2A vs. 3A, two-way ANOVA).
No significant changes over preoperative values were
obtained on the contralateral foot.
The injection of AdKir and its induction at the time of
the CCD surgery resulted in a significantly lesser degree
of hyperalgesia (higher FWTs) in the ipsilateral foot than
that obtained in response to CCD with control vector or
vehicle (Figure 3A). This indicated that the expression of
inward-rectifying potassium channel could partially
prevent the development of mechanical hyperalgesia.
Figure 1 The structure and method of application of the viral vectors. A: Schematic representation of the ecdysone-inducible adenovirus
vectors and method of application to the DRG. ITR: inverted terminal repeat; ψ: Packaging signal; Ecd promoter: ecdysone-inducible promoter;
EGFP: enhanced green fluorescent protein; IRES: internal ribosome entry site; MCS, multiple cloning site; pA, SV40 polyadenylation signal; DBEcR,
hybrid ecdysone receptor. AdCDBEcR: receptor virus. AdEGI: the control vector containing only the EGFP gene. AdEGI-Kir2.1: the viral vector
containing both the EGFP and the Kir2.1 gene, which encodes an inward-rectifying potassium channel (See main text and Johns et al. 1999 [9]
for further details). B: Procedures for sub-epineurial injection of viral vectors into the L4 DRG and rod implantation. Under a dissecting
microscope, the L5 transverse process was removed to expose the L4 spinal nerve. A polyethylene tube (tip diameter 100 μm) connected to a
microinjection syringe was inserted into the L4 spinal nerve under the epineurium until the tip reached the center of DRG. The viral vectors or
vehicle were slowly injected into the sub-epineurial space of DRG using a microinjection pump (5 μL in about 10 min). For CCD surgery, a
stainless steel rod was inserted into the intervertebral foramen to compress the L4 DRG.
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Page 2 of 9Figure 2 Behavioral effects of the adenoviral vector in the absence of CCD. Either the vehicle, the control vector (AdEGI), or the vector
containing the Kir2.1 gene (AdKir) was delivered to the L4 DRG via a sub-epineurial injection. The induction agent was then delivered, IP (arrow),
either immediately (postoperative day 0) (A) or after a delay of three days (B). In either case, a second induction was delivered on the 10
th
postoperative day. FWT: Mean threshold force (mN) for foot withdrawal. Injection of vehicle alone produced on the ipsilateral foot, a transient
mechanical hyperalgesia (significant decrease in FWT from preoperative values) that recovered within 5 days (A). Ipsilateral (Ipsi) but not
contralateral (Con) to the CCD, an injection of vehicle containing either AdEGI or Adkir, produced a mild and long-lasting mechanical
hyperalgesia regardless of whether the inducing agent was given immediately or after a delay of 3 days suggesting that the hyperalgesia
produced by the presence of virus was not reduced by the expression of Kir. *: P < 0.05 vs. pre-operative mean for the ipsilateral foot of AdEGI
group and AdKir groups (A and B); †: P < 0.05 vs. pre-operative mean for the ipsilateral foot of Vehicle group (A).
Figure 3 Behavioral effects of adenoviral vectors in CCD rats. At day 0, either the vehicle, the control vector (AdEGI), or the vector containing
the Kir2.1 gene (AdKir) was delivered to the L4 DRG via sub-epineurial injection. The ganglion was then compressed (closed arrowhead). The
inducing agent was delivered by IP injection (open arrow) either immediately (A) or after a delay of 3 days (B). In either case, the inducing agent
was delivered again at postoperative day 10. Same format as Figure 2. Hyperalgesia (decreased mean foot withdrawal threshold, FWT) after CCD
was obtained on the ipsilateral (Ipsi) but not contralateral (Con) foot. The magnitude of hyperalgesia produced by CCD (A,B, open squares, solid
lines) was the same with or without the presence of the control virus (A, solid squares, dashed lines) and was greater than that produced by the
control or AdKir viral vectors in the absence of CCD (Figure 2, open and closed squares). The increased hyperalgesia produced by CCD, in
comparison with that produced by the viral vectors alone was significantly reduced by the induction of AdKir (A, solid squares, solid line) but only if
the induction occurred at the time of compression and not if it occurred after a delay of 3 days (B). *: P < 0.05 vs. pre-operative mean for the
ipsilateral foot of all groups in A-C; †: P < 0.05, AdKir vs. AdEGI or vehicle group for the ipsilateral foot (A).
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the hyperalgesia caused by CCD (Figure 3B).
AdKir significantly reduced the neuronal hyperexcitability
in chronically compressed DRG neurons
Under the fluorescent microscope, GFP was detected in
approximately half of the neurons in the DRG injected
with viral vectors (AdEGI: 52% or 66/128, AdKir: 51%
or 64/126). Unless otherwise stated, all the neurons
recorded were with GFP (Figure 4F inset), confirming
the successful expression of target gene transferred by ade-
noviral vectors. In vivo intracellular recording was
obtained from a total of 130 DRG neurons, including 31
neurons from AdEGI-injected rats, 28 from AdKir-injected
rats, 35 from AdEGI+CCD rats and 36 from AdKir+CCD
rats. The average somal diameter (Figure 4A) or dorsal
root conduction velocity (Figure 4B) of neurons within
each size category was not significantly different between
these groups.
Among the 130 DRG neurons recorded, peripheral
receptive fields were found in 60 neurons, including 35
large-, 17 medium- and 8 small-sized neurons. The
large sized neurons included: 12 MSs, 16 LTMs with
A-fibers (ALTMs) that were rapidly adapting (RA) to
steady pressure (10 Guard-hair, 1 Down-hair and 5 glab-
rous), 5 slowly adapting (SA) ALTMs (3 hairy skin and
2 glabrous) and 2 mechanosensitive nociceptors with
A-fibers (AMs). The medium sized neurons included:
5M S s ,6R AA L T M s( 2G - h a i r ,3D - h a i ra n d1g l a b -
rous), 5 AMs and 1 AMH. The 8 small sized neurons
included 4 CMs and 4 CMHs. The percentage and func-
tional characteristics of receptive fields were not signifi-
cantly different between animals in the AdEGI and
AdKir, or in the control and CCD groups. The neurons
with different receptive field characteristics were pooled
for these groups due to the relatively small sample sizes.
The electrophysiological properties recorded from
AdEGI-injected rats were not significantly different from
those of vehicle-injected rats and were similar to those
published for naïve rats [3,10]. CCD surgery produced
neuronal hyperexcitability as indicated by a significantly
lower current threshold (rheobase, reduced by approxi-
mately 50%) and the presence of spontaneous activity
(in about 11.4% AdEGI-infected neurons), without any
significant effect on resting membrane potential (RMP),
input resistance (Rin) or dorsal root conduction velocity
(CVdr) (Figure 4). These results agreed with previously
published studies on the rat CCD model using the in-
vitro intracellular recording techniques in our laboratory
[3,5,11] and others [12,13].
Similar effects were found within large-, medium- and
small-sized DRG neurons. In comparison with neurons
infected with AdEGI, and regardless of size or subjected
to CCD or not, neurons infected with AdKir exhibited a
significantly more hyperpolarized resting potential
(Figure 4C) and a lower input resistance (Figure 4D).
CCD surgery produced a significant reduction of rheo-
base in AdEGI-infected DRG neurons (Figure 5A and
5B), but the effect was reversed by AdKir infection
(Figure 5C; summarized in Figure 4E). The expression
of Kir current (indicated by green fluorescence) also
inhibited the spontaneous activity (SA) in CCD neurons.
CCD surgery produced SA in 11.4% of DRG neurons
transfected with the control vector, AdEGI. In AdKir-
injected and chronically compressed DRGs, none of the
neurons expressing GFP were spontaneous active, sug-
gesting that expression of the Kir2.1 channel inhibited
the CCD-induced SA. However, SA was still found in
9.4% (3/32) of the neurons that did not express GFP in
the same DRG (Figure 4F), indicating the presence of
hyperexcitability in the CCD neurons not infected with
adenoviral vectors.
Discussion
We used an inducible adenoviral vector to transfer the
inwardly rectifying potassium channel Kir2.1 directly into
the DRG under compression. Encoded by the KCNJ2
gene, Kir2.1 is an inwardly rectifying potassium channel
widely expressed in heart, blood vessels, skeleton mus-
cles, brain as well as the Schwann cells in the peripheral
nervous system [14]. Kir2.1 is believed to play a critical
role in the stabilization of resting membrane potential
and the modulation of cellular excitability in these tis-
sues. A mutation of Kir2.1 contributes to a number of
genetic disorders such as Andersen’s syndrome [14,15].
The efficacy of the gene transfer method used in this
study has been demonstrated in previous studies of neu-
rons in the superior cervical ganglion neurons [6] and
also in cardiac myocytes [7,16,17]. Our approach of sub-
epineurial injection has the advantage of producing mini-
mal side effects such as collateral tissue damage and
nerve conduction block. The inducible nature of the ade-
noviral vector, controlled by IP injection of the inducing
agent, also increases the safety of gene transfer. As
shown in the electrophysiological recording experiments,
AdKir significantly reduced the excitability, without alter-
ing the conduction velocity, of neurons in both control
and CCD rats. Specifically, in comparison with the effects
of vehicle or a control vector containing only the GFP
gene, neurons infected with AdKir displayed a hyperpo-
larized RMP, a decreased Rin and a higher rheobase. The
CCD-induced hyperexcitability, as characterized by a
reduction of rheobase and increased incidence of SA, was
almost totally eliminated in these AdKir-infected neu-
rons. The development of mechanical hyperalgesia could
be partially prevented if the Kir2.1 gene was induced at
the beginning of CCD surgery. Taken together, our find-
ings indicate that the expression of Kir2.1 by an inducible
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Page 4 of 9Figure 4 Comparison of electrophysiological properties of DRG neurons after gene transfer and chronic compression.C o m p a r i s o n s
were made among the parameters of recordings obtained in vivo from DRG neurons infected with AdEGI (the control vector) or AdKir (vector
expressing Kir current) in rats with or without CCD surgery. Similar effects were found within large-, medium- and small-sized DRG neurons.
There was no significant difference in the somal diameter (A) and dorsal root conduction velocity (B) among different groups. Neurons infected
with AdKir showed a significantly hyperpolarized resting potential (C) and lower input resistance (D) in comparison to those infected with AdEGI
regardless of the presence or absence of CCD, which did not affect these two parameters. E: CCD surgery produced a significant reduction of
rheobase in AdEGI-infected DRG neurons, but the effect was reversed by AdKir infection. F: Expression of Kir current (indicated by green
fluorescence) also inhibited the spontaneous activity (SA) in CCD neurons. However, SA was still found in some neurons that did not express
GFP in the same DRG. Inset in F: Reflected light (REF) and fluorescent (GFP) microscopic image showing the presence of viral-transferred GFP in
the DRG neurons. Scale bar: 20 μm. *: P < 0.05 vs. AdEGI+CCD; †: P < 0.05 vs. AdEGI.
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reduce the neuronal hyperexcitability and mechanical
hyperalgesia produced by CCD.
However, our study also revealed some limitations of
this gene transfer method. First, a local injection of the
adenoviral vectors (AdEGI or AdKir) produced a mild but
long-lasting mechanical hyperalgesia in naïve rats. Because
the injection of vehicle only caused a transient effect
(hyperalgesia lasted for less than 5 days), the prolonged
hyperalgesia was likely due to a local inflammation
induced by the adenoviral vectors rather than the surgical
p r o c e d u r ep e rs e .T h i ss i d ee f f e c tm a yb er e s o l v e db y
using other viral vectors (e.g. adeno-associated virus) that
potentially cause less tissue inflammation. Secondly,
although the expression of Kir effectively reduced the neu-
ronal excitability and eliminated the CCD-induced SA,
only about half of the neurons in the DRG were success-
fully transfected with the target gene as indicated by GFP.
In the AdKir-injected, compressed DRGs, uninfected
(GFP-negative) neurons still remained hyperexcitable as
indicated by an incidence of SA (9.4%) comparable to that
of neurons in DRGs injected with the control-vector
(11.4% SA, Figure 4). These results may partially explain
the failure of relieving the hyperalgesia in the case of a
delayed induction of the Kir2.1 gene. Although the elec-
trophysiological effects were similar for neurons receiving
immediate vs. delayed induction (i.e. excitability was
reduced in about half of DRG neurons), a higher level of
neuronal hyperexcitability in the DRG may be required to
initiate than to maintain the hyperalgesia. Maintenance of
chronic pain may result from mechanisms of sensitization
of central neurons [18], which, once activated, are more
difficult to reverse even after the initial phase even if the
input from peripheral injury site is subsequently blocked
[19]. Therefore the neuronal hyperexcitability contributing
to chronic pain is best inhibited as soon as possible after
injury.
Conclusion
We delivered, by microinjection into the fourth lumbar
DRG in rats, an inducible adenoviral vector containing a
reporter gene encoding an inwardly rectifying potassium
channel Kir2.1. The expression of the channel was
induced either immediately or three days after the onset
of a chronic compression of the DRG (CCD model of
neuropathic pain). In ether case, expression of Kir2.1 sig-
nificantly reduced the CCD-induced hyperexcitability of
functionally characterized DRG neurons, electrophysiolo-
gically recorded in vivo. However, only the immediate
and not the delayed induction of Kir2.1 significantly
reduced the hyperalgesia that otherwise occurred on the
hindpaw ipsilateral to the DRG. We hypothesize that a
higher level of neuronal hyperexcitability in the DRG is
required to initiate than to maintain the hyperalgesia and
that the hyperexcitability contributing to neuropathic
pain is best inhibited as soon as possible after injury.
Methods
Ecdysone-inducible adenovirus vector constructs
The construction of the ecdysone-inducible adenovirus
vector has been described [6,7]. The viral vectors were
produced in the Wilmer Gene Vector Core at The Johns
Hopkins University School of Medicine (Baltimore,
MD). The following three types of viral vectors were used
(Figure 1A):
1) The control viral vector (AdEGI) containing only
the EGFP (enhanced green fluorescent protein) gene.
Figure 5 AdKir reversed the CCD-induced hyperexcitability in DRG neurons. Typical intracellular recordings (Vm) were obtained from the
somata of DRG neurons transfected with AdEGI (A), AdEGI plus CCD surgery (B) or AdKir plus CCD surgery (C). Current steps (Ic) were injected
to obtain the rheobase and input resistance. All three neurons are Ab-type with large-diameter somata. The rheobase of DRG neurons with
control vector AdEGI decreased remarkably after CCD surgery, but this effect was reversed by AdKir.
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t h eK i r 2 . 1g e n et h a te n c o d e st h eK i r 2 . 1c h a n n e l
(AdKir).
3) The receptor virus AdCDBEcR containing the
ecdysone-inducible promoter that is subsequently
m i x e dw i t hA d E G Io rA d K i ra tar a t i oo f1 : 2b e f o r e
application to the DRG. This enables the expression
of target gene in the viral vectors to be controlled
externally via a systemic injection of ecdysone
analog[6,7].
Surgical procedures
Adult female Sprague-Dawley rats weighing 200-250 g
(n = 48 total) were housed in groups of three or four in
a climate-controlled room under a 12 hr light/dark
cycle. The use and handling of animals were approved
by the Institutional Animal Care and Use Committee of
t h eY a l eU n i v e r s i t yS c h o o lo fM e d i c i n ea n dw e r ei n
accordance with guidelines provided by the National
Institutes of Health and the International Association
for the Study of Pain.
Sub-epineurial injection of viral vectors into rat DRG
Animals were deeply anesthetized with pentobarbital
sodium (Nembutal, 50 mg/kg i.p.). Under a dissection
microscope, the L5 transverse process was removed to
expose the L4 spinal nerve. A polyethylene tube (tip dia-
meter 100 μm) connected to a microinjection syringe
was inserted into the L4 spinal nerve under the epineur-
ium until the tip reached the center of DRG (Figure 1).
The solution was slowly injected into the sub-epineurial
space of DRG using a microinjection pump (5 μLi n
about 10 min). The adenoviral vectors AdEGI (contain-
ing EGFP gene only) or AdKir (containing both EGFP
and Kir gene) were pre-mixed with the receptor virus
AdCDBEcR (containing the ecdysone-inducible promo-
ter) at a ratio of 2:1 and delivered to the DRG.
The dose of viral vectors was 10
8 to 10
10 viral particles
in 5 μL of vehicle consisting of 0.7% NaCl and 5% sucrose.
The vehicle containing no virus was used as a control.
Briefly this two viral system works in the following way.
The modified ecdysone receptor virus expresses a modi-
fied ecdysone receptor which in the presence of an ecdy-
sone analog binds to the cell’s native Retinoid X Receptor
(RXR). This complex then anneals to the upstream portion
(promoter) region of the ion channel virus DNA causing
strong expression of the ion channel and/or the GFP
reporter. The ecdysone receptor was modified in two ways
o n et oh a v eas t r o n g e ra f f i n i t yf o rt h en a t i v eR X Ra n dt o
bind the ecdysone analog, GS-E (N-(3-methoxy-2-ethyl-
benzoyl)-N’-(3,5-dimethylbenzoyl)-N’-tert-butylhydrazine,
now known as RL1, New England Biolabs, Ipswich, MA).
GS-E (45 mg in 100 μL DMSO, IP injection) was used as
the inducing agent to control the time at which the
expression of the transferred genes began. As previously
shown, a single injection of inducing agent is sufficient to
induce the expression of a target gene transferred by ade-
noviral vectors starting 24 hours and lasting for at least
10 days [7].
Rod implantation to compress the rat DRG
Immediately after sub-epineurial injection, the tube was
removed and rod implantation (CCD surgery) was per-
formed on the L4 DRG as described [1,2,4]. Briefly, the
intervertebral foramen of L4 was exposed, and an
L-shaped stainless steel rod (0.63 mm in diameter and 4
mm in length) was inserted to compress the L4 DRG.
The incision was closed in layers. The correct placement
of the implanted rod was confirmed when the ganglion
was exposed for electrophysiological recording [4].
CCD surgery was performed in a total of 24 rats,
including 12 injected with AdKir, 6 with AdEGI and 6
with vehicle. Another group of 24 rats, including 8
injected with AdKir, 9 with AdEGI and 6 with vehicle,
did not receive rod implantation.
Behavioral tests
Behavioral tests were administered on each of three
consecutive days before and up to 14 days after viral
vectors injection and rod implantation. Tests were car-
ried out without knowledge of the type of surgery and
electrophysiological results. Before testing, the rat was
placed in a clear plastic cage with a metal mesh floor.
After about 15 minutes of accommodation, the follow-
ing tests were performed.
Measurement of the threshold force eliciting withdrawal to
punctate indentation
A series of Von-Frey-type monofilaments each deliver-
ing a different bending force in ascending order (10, 20,
40, 60, 80, 100 and 120 mN) but having the same tip
diameter of 0.1 mm were delivered to designated loci on
the skin [4,10]. Each filament was applied for 1 sec,
alternately to each foot and at intervals of 10 to 15 s, to
each of 6 sites distributed across the plantar surface of
the rat hindpaw. A Hill equation was fitted (Origin Ver-
sion 6.0, Microcal Software, Inc.) to the function relating
the percentage of indentations eliciting a withdrawal to
the force of indentation. From this equation, the thresh-
old force was obtained, defined as the force correspond-
ing to a 50% withdrawal. Cutaneous hyperalgesia was
defined as a postoperative decrease in threshold of 20
mN from the mean of the three preoperative thresholds.
In-vivo intracellular electrophysiological recording
In-vivo, intracellular electrophysiological recordings
were obtained from visualized neuronal somata on the
surface of the DRG [20] in 18 control animals and in 20
CCD rats starting 3-5 days after injection of the indu-
cing agent. The surgical and recording procedures were
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anesthesia (initial dose of 50 mg/kg i.p. followed by
20 mg/kg per hour as needed), the L5 transverse process
was removed to expose the L4 spinal nerve, and a lami-
nectomy was performed at the levels of L1-L6. The L4
DRG was exposed, and the L4 dorsal roots transected
just prior to their entry to the spinal cord. Oxygenated
ACSF was dripped periodically on to the surface of the
ganglia during the surgical procedure. Under a dissect-
ing microscope, the sheath covering the surface of the
DRG (perineurium and epineurium) was carefully
removed using fine forceps and scissors. Animal was
transferred to a platform attached to the recording
table. The spinal processes were clamped at T12 and S1
region, and a skin pool was formed by suturing to a
metal ring. The ganglion was then placed on a spoon-
shaped platform under the microscope (BX50WI, Olym-
pus Optical, Tokyo, Japan). The platform holding the
ganglion and the animal were mechanically isolated
from each other allowing the lower limb to be manipu-
lated during the search for receptive fields without
transmitting unwanted mechanical stimuli to the
recorded cell. The DRG was continuously perfused at a
rate of 3~4 ml/min with oxygenated artificial cerebrosp-
inal fluid (ACSF). The ACSF contained (in mM): 130
NaCl, 3.5 KCl, 24 NaHCO3,1 . 2 5N a H 2PO4, 1.2 MgCl2,
1.2 CaCl2,a n d1 0D e x t r o s e .T h es o l u t i o nw a sb u b b l e d
with 95% O2 and 5% CO2 and had a pH of 7.4 and an
osmolarity of 290~310 mOsm. The temperature of the
ACSF around the ganglion was maintained at about 35°
C by a heater and controller (TC-344A, Warner Instru-
ment, Hamden, CT). The intracellular recording electro-
des, fabricated from borosilicate glass (World Precision
Instruments, Sarasota, FL), were pulled on a Flaming/
Brown micropipette puller (P-97, Sutter Instrument,
Novato, CA) and filled with 1.0 M KCl (impedance:
40~80 MΩ). Electrical pulses were delivered through
a suction electrode applied at the cut end of the
dorsal root.
Electrophysiological recordings were collected with
bridge mode under current clamp using an AxoClamp-
2B (Molecular Devices, Palo Alto, CA), stored digitally
via a Digidata 1322A interface, and analyzed offline with
pClamp 8 software (Molecular Devices). The electrode
resistance was balanced by a bridge circuit in the ampli-
fier. A neuron was accepted for study only when it
exhibited a resting membrane potential (RMP) more
negative than -45 mV. Current steps, each 100 ms dura-
tion, were delivered through the intracellular recording
electrode in increments of 0.05 nA from -0.5 to 4 nA.
The input resistance (Rin, MΩ) was calculated from the
slope of a steady-state I-V plot obtained from responses
to a series of hyperpolarizing currents steps from -0.5 to
-0.05 nA. The current threshold (Rheobase, nA) was
defined as the minimal depolarizing current required to
evoke an action potential.
Classification of neurons
The neurons on surface of the DRG were viewed with
reflected-light epi-illumination or by epifluorescence
[20]. The fluorescent mode enabled the confirmation of
the presence of GFP and thereby the expression of tar-
get gene (Figure 5D inset). Using the reflected-light
mode of viewing, a neuron to be recorded was initially
selected according to the size of its soma and, based on
the mean of its longest and shortest diameter, categor-
ized as small (S, < = 30 μm), medium (M, 31~45 μm) or
large (L, >45 μm) [5,10]. A dorsal-root axon was classi-
fied as a C-, Aδ-, or Aa/b- fiber according to whether
its respective dorsal root conduction velocity (CVdr)
was < 1.2 m/s, < 7.5 or >7.5 m/s [5,11,21].
Each neuron was further classified by its receptive field
properties using a limited set of mechanically delivered
search stimuli. Aside from gentle extension/flexion of the
toes or angle used to identify neurons with muscle spin-
dles, ("MS”). the search stimuli were applied primarily to
the skin of the foot and lower leg. A cutaneous neuron
was initially broadly categorized as either “low-threshold”
mechanosensitive (LTM) if it responded readily to gentle
pressure or stroking of the skin with the experimenter’s
finger or “nociceptive” if it could only be activated by
mildly noxious stimuli such as pinching of the skin
(experimenter’s thumb and forefinger). A glass probe was
used to outline the borders of the receptive field.
Nociceptive neurons were further classified by whether
they responded to noxious heat or cold stimuli. Heat
stimuli were delivered by a contact thermode consisting
of a chip resistor (2 × 3 mm
2) that delivered precise con-
trol over temperatures the skin/thermode interface. Each
heat stimulus was a ramp (20°C/sec) from a controlled
base temperature of 38°C to a plateau (51°C) which was
maintained for 5 sec followed by passive cooling back to
base. The cold stimulus was produced by an ice chip that
was placed on the skin for 20 sec. Nociceptive neurons
responsive to noxious mechanical, heat and cold with A-
or C-fibers were termed A- or CMH and, if responsive to
cold, A- or CMHCs.
Statistical Analyses
Data values are presented as means with standard errors
of the mean. Statistical analysis was performed using
SigmaStat (Version 2.03, SPSS Inc. San Rafael, CA)
computer software. Student’s t-tests were used to deter-
mine the statistical significance of differences between
means obtained from two different groups of neurons.
One- or two-way analyses of variance (ANOVAs)
followed by post hoc pairwise comparisons (Student-
Newman-Keuls method) were used to determine the
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obtained from three or more experimental groups. For a
given foot, the mean threshold forces to elicit foot with-
drawal to punctuate indentation obtained for each of
the four surgical groups were analyzed with a two-way
ANOVA (group × days) with repeated measures on
days. Post hoc contrasts determined the significance of
differences between the mean of the three preoperative
tests and the mean obtained for each postoperative test.
Chi-Square tests were used to assess differences in the
percentages of neurons with SA. A probability of 0.05
was chosen as the criterion for significance.
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